Top compounds associated with response to GTF2E1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.06
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC -0.13 0.06
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.07 0.07
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC -0.067 0.07
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.07
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.063 0.07
mRNA brivanib CTRPv2 pan-cancer AAC 0.066 0.07
mRNA PD-0325901 CCLE pan-cancer AAC -0.079 0.07
mRNA PD173074 GDSC1000 pan-cancer AAC -0.065 0.07
mRNA TW 37 GDSC1000 pan-cancer AAC 0.061 0.07
Download CSV